Romiplostim as Early Treatment of Immune Thrombocytopenia With Severe Immunodeficiency

Hematology Reports - Italy
doi 10.4081/hr.2012.e10
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

PAGEPress Publications

Related search

Total Remission of Severe Immune Thrombocytopenia After Short Term Treatment With Romiplostim

Hematology Reports
Hematology
2011English

Erratum To: Treatment of 5 Dogs With Immune-Mediated Thrombocytopenia Using Romiplostim

BMC Veterinary Research
MedicineVeterinary
2016English

Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia

American Journal of Hematology
Hematology
2018English

Self-Administration of Romiplostim in Patients With Chronic Immune Thrombocytopenia

Community Oncology
2013English

Evolution of Platelet Function in Adult Patients With Chronic Immune Thrombocytopenia on Romiplostim Treatment

British Journal of Haematology
Hematology
2019English

Highly Fluctuating Thrombocytopenia Developing in a Patient With Immune Thrombocytopenia (ITP) While Administering Romiplostim

Internal Medicine
Internal MedicineMedicine
2012English

The Efficacy and Safety of Romiplostim in Adult Patients With Chronic Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2012English

Romiplostim for the Management of Perioperative Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy